27th May 2021 4:36 pm |
RNS |
Price Monitoring Extension |
27th May 2021 7:00 am |
RNS |
AstraZeneca prices a EUR800m bond offering |
26th May 2021 9:24 am |
RNS |
Stabilisation Notice |
26th May 2021 7:00 am |
RNS |
AstraZeneca prices a $7bn bond offering |
25th May 2021 7:00 am |
RNS |
EMTN programme update - publication of Prospectus |
21st May 2021 7:00 am |
RNS |
Vaxzevria COVID-19 vaccine approved in Japan |
18th May 2021 3:30 pm |
RNS |
Director/PDMR Shareholding |
11th May 2021 2:00 pm |
RNS |
Result of AGM |
11th May 2021 1:55 pm |
RNS |
Shareholders vote in favour of Alexion acquisition |
7th May 2021 7:00 am |
RNS |
Imfinzi + tremelimumab showed survival in POSEIDON |
5th May 2021 6:30 pm |
RNS |
Holding(s) in Company |
4th May 2021 3:00 pm |
RNS |
Total Voting Rights |
4th May 2021 7:00 am |
RNS |
Farxiga approved in the US for CKD |
30th Apr 2021 7:00 am |
RNS |
AZN: First quarter 2021 results |
26th Apr 2021 7:10 am |
RNS |
Selumetinib recommended for EU approval in NF1 |
26th Apr 2021 7:05 am |
RNS |
Tagrisso adjuvant receives positive CHMP opinion |
26th Apr 2021 7:00 am |
RNS |
Nirsevimab Phase III trial met primary endpoint |
16th Apr 2021 12:00 pm |
RNS |
US clearance of proposed acquisition of Alexion |
14th Apr 2021 7:00 am |
RNS |
Tagrisso approved in China in early lung cancer |
12th Apr 2021 1:00 pm |
RNS |
Circular and notice of general meeting |
12th Apr 2021 7:00 am |
RNS |
Update on Farxiga COVID-19 DARE-19 Phase III trial |
1st Apr 2021 3:00 pm |
RNS |
Total Voting Rights |
30th Mar 2021 12:15 pm |
RNS |
Notice of AGM |
25th Mar 2021 3:00 pm |
RNS |
Director/PDMR Shareholding |
25th Mar 2021 7:00 am |
RNS |
AZD1222 US Ph3 primary analysis confirms efficacy |
22nd Mar 2021 7:00 am |
RNS |
AstraZeneca US vaccine trial met primary endpoint |
16th Mar 2021 7:05 am |
RNS |
Divestment of Viela shareholding completed |
16th Mar 2021 7:00 am |
RNS |
US supply agreement for additional AZD7442 doses |
9th Mar 2021 3:00 pm |
RNS |
Director/PDMR Shareholding |
4th Mar 2021 3:00 pm |
RNS |
Designation of EU home member state |
3rd Mar 2021 7:00 am |
RNS |
US court decision favours Symbicort patents |
2nd Mar 2021 7:00 am |
RNS |
Further update on roxadustat US regulatory review |
1st Mar 2021 3:00 pm |
RNS |
Total Voting Rights |
22nd Feb 2021 7:00 am |
RNS |
Voluntary withdrawal Imfinzi US bladder indication |
17th Feb 2021 7:00 am |
RNS |
Lynparza: IDMC recommend early analysis of OlympiA |
16th Feb 2021 11:15 am |
RNS |
Filing of Form 20-F with SEC |
15th Feb 2021 3:00 pm |
RNS |
Director/PDMR Shareholding |
15th Feb 2021 11:00 am |
RNS |
Annual Financial Report |
11th Feb 2021 7:01 am |
RNS |
AstraZeneca Non-Executive Board changes |
11th Feb 2021 7:00 am |
RNS |
AZN: full-year 2020 results |